⚠ Novel chemotype — no close known analogue (best Tanimoto < 0.3). Unexplored chemical space relative to ChEMBL.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| Methylamine SCHEMBL20570915 | 0.97 | — | — | |
| SCHEMBL1670 | 0.81 | — | — | |
| SCHEMBL754334 | 0.81 | TDP1 (0.31) | — | |
| SCHEMBL9397770 | 0.78 | — | — | |
| SCHEMBL27701016 | 0.78 | — | — | |
| SCHEMBL28082245 | 0.78 | — | — | |
| SCHEMBL28182677 | 0.78 | — | — | |
| Bromide SCHEMBL28123900 | 0.78 | — | — | |
| SCHEMBL28871555 | 0.75 | — | — | |
| SCHEMBL28240029 | 0.75 | — | — |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 26 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-11472801-B2 | Crystalline forms of a FGFR inhibitor and processes for preparing the same | INCYTE CORPORATION (US) | 2022-10-18 | — | — | US | claimed |
| US-20200270245-A1 | CRYSTALLINE FORMS OF A FGFR INHIBITOR AND PROCESSES FOR PREPARING THE SAME | INCYTE CORPORATION | 2020-08-27 | — | — | US | claimed |
| EP-3630762-A1 | CRYSTALLINE FORMS OF A FGFR INHIBITOR AND PROCESSES FOR PREPARING THE SAME | Incyte Corporation (US) | 2020-04-08 | — | — | EP | claimed |
| US-20190055237-A1 | CRYSTALLINE FORMS OF A FGFR INHIBITOR AND PROCESSES FOR PREPARING THE SAME | INCYTE CORPORATION | 2019-02-21 | — | — | US | claimed |
| WO-2018218100-A1 | CRYSTALLINE FORMS OF A FGFR INHIBITOR AND PROCESSES FOR PREPARING THE SAME | INCYTE CORPORATION (US) | 2018-11-29 | — | — | WO | claimed |
| EP-4692090-A1 | TRICYCLIC COMPOUND AS ATR KINASE INHIBITOR | Shanghai Fosun Pharmaceutical (Group) Co., Ltd. (CN) | 2026-02-11 | — | — | EP | disclosed |
| EP-4688768-A1 | NOVEL METTL3 INHIBITORS AND USE THEREOF IN THERAPY | Novalix (FR) | 2026-02-11 | — | — | EP | disclosed |
| CN-119013266-A | Novel GSPT compounds and methods of use of novel compounds | 百时美施贵宝公司 | 2024-11-22 | — | — | CN | disclosed |
| WO-2024200835-A1 | NOVEL METTL3 INHIBITORS AND USE THEREOF IN THERAPY | NOVALIX (FR) | 2024-10-03 | — | — | WO | disclosed |
| US-20240294498-A1 | FACTOR XIIA INHIBITORS | LUNAC THERAPEUTICS LTD (GB) | 2024-09-05 | — | — | US | disclosed |
| EP-4347578-A1 | FACTOR XIIA INHIBITORS | Lunac Therpeutics Ltd (GB) | 2024-04-10 | — | — | EP | disclosed |
| CN-117751112-A | Heteroaryl-3-piperidinedione compounds and application thereof | 南京明德新药研发有限公司 | 2024-03-22 | — | — | CN | disclosed |
| US-20200270245-A1 | CRYSTALLINE FORMS OF A FGFR INHIBITOR AND PROCESSES FOR PREPARING THE SAME | INCYTE CORPORATION | 2020-08-27 | — | — | US | disclosed |
| US-20200172539-A1 | Azalactam Compounds as HPK1 Inhibitors | PFIZER INC. (US) | 2020-06-04 | — | — | US | disclosed |
| EP-3630762-A1 | CRYSTALLINE FORMS OF A FGFR INHIBITOR AND PROCESSES FOR PREPARING THE SAME | Incyte Corporation (US) | 2020-04-08 | — | — | EP | disclosed |
| US-10611762-B2 | Crystalline forms of a FGFR inhibitor and processes for preparing the same | INCYTE CORPORATION (US) | 2020-04-07 | — | — | US | disclosed |
| US-20190055237-A1 | CRYSTALLINE FORMS OF A FGFR INHIBITOR AND PROCESSES FOR PREPARING THE SAME | INCYTE CORPORATION | 2019-02-21 | — | — | US | disclosed |
| WO-2018218100-A1 | CRYSTALLINE FORMS OF A FGFR INHIBITOR AND PROCESSES FOR PREPARING THE SAME | INCYTE CORPORATION (US) | 2018-11-29 | — | — | WO | disclosed |
| US-9839642-B2 | Beta-tetrazolyl-propionic acids as metallo-beta-lactamase inhibitors | MERCK SHARP & DOHME CORP. (US) | 2017-12-12 | — | — | US | disclosed |
| US-20170173035-A1 | BETA-TETRAZOLYL-PROPIONIC ACIDS AS METALLO-BETA-LACTAMASE INHIBITORS | MERCK SHARP & DOHME CORP. (US) | 2017-06-22 | — | — | US | disclosed |